Bank Of Jackson Hole Trust Halozyme Therapeutics, Inc. Transaction History
Bank Of Jackson Hole Trust
- $150 Billion
- Q4 2024
A detailed history of Bank Of Jackson Hole Trust transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Bank Of Jackson Hole Trust holds 68 shares of HALO stock, worth $3,939. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68Holding current value
$3,939% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
534Shares Held
123MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$1.02 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$747 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$384 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$235 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$197 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.07B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...